Drug Preferences Among Patients And Physicians For Diagnosed Dyslipidemia Overview The study focused on evaluating patient and physician drug preferences regarding lipid-lowering drugs, particularly proprotein convertase subtilisin/kexin type 9 inhibitors, as an alternative to statins for dyslipidemia treatment. Employing an online discrete choice experiment (DCE), the research aimed to ascertain the relative
Tag: atherosclerosis
Community Hypertension and Atherosclerosis Risk
Community Hypertension and Atherosclerosis Risk Elevated blood pressure (BP) is considered one of the key risk factors in deaths caused by cardiovascular and renal problems. Despite the increase in awareness about hypertension and the advancements in treatment through the last decades, many patients still suffer from elevated BP while on treatment.
